Session Details

F019 Caring for the Cancer Patient: Challenging Cases From Inpatient and Outpatient Oncodermatology Consultative Services

Fri, Mar 8, 1:00 PM - 3:00 PM
Room 25B
2 CME Available Forum
View Map

DESCRIPTION

Open admission to eligible categories, no tuition or ticket

Dermatologic issues are one of the most common complications in patients undergoing cancer therapy. Knowledge of mucocutaneous toxicities to chemotherapy, immunotherapy, and radiation, neoplasms in cancer patients (particularly cutaneous metastases), paraneoplastic syndromes, complications of stem cell transplant, and infectious diseases of the immunosuppressed is critical in distinguishing the numerous dermatologic conditions that can arise in a patient undergoing cancer treatment. This session will cover these key topics in the field of Oncodermatology through illustrative and challenging cases seen at different academic cancer centers to enhance the knowledge of dermatologists, residents, and other practitioners caring for cancer patients.

LEARNING OBJECTIVES

1.

Identify possible challenging side effects of chemotherapy, immunotherapy, and/or radiation and discuss potential management strategies.

2.

Discuss possible challenging long-term manifestations of cancer treatment, such as graft-versus-host disease after stem cell transplant or medication side effects, and discuss potential management strategies.

3.

Identify potential infectious diseases that can occur in the setting of immunosuppression due to cancer therapy, as well as manifestations of cutaneous metastases.

SCHEDULE

9:00 PM

Introduction

Jennifer N. Choi, MD, FAAD

9:05 PM

Challenging Cases from MD Anderson Cancer Center

Susan Chon, MD, FAAD

9:35 PM

Challenging Cases from NYU Cancer Center

Ian Tattersall, MD, PhD, FAAD

10:05 PM

Challenging Cases from Tufts Cancer Center

Sandhya Chowdary Deverapalli, MD, FAAD

10:35 PM

Challenging Cases from Northwestern Robert H. Lurie Cancer Center

Jennifer N. Choi, MD, FAAD

SPEAKERS

Jennifer N. Choi, MD, FAAD

Jennifer N. Choi, MD, FAAD

Susan Chon, MD, FAAD

Susan Chon, MD, FAAD

Sandhya Chowdary Deverapalli, MD, FAAD

Sandhya Chowdary Deverapalli, MD, FAAD

Ian Tattersall, MD, PhD, FAAD

Ian Tattersall, MD, PhD, FAAD

SPEAKER DISCLOSURES

Jennifer N. Choi, MD, FAAD

Azitra, Inc – Advisory Board(Fees); CeraVe/Valeante – Independent Contractor(Fees); Incyte Corporation – Investigator(Grants/Research Funding); La Roche-Posay Laboratorie Pharmaceutique – Advisory Board(Fees); OnQuality Pharmaceuticals, Ltd. – Advisory Board(Fees); Parexel – Data Safety Monitoring Board(Fees); PraHealth Sciences – Advisory Board(Fees); Regeneron Pharmaceuticals, Inc. – Data Safety Monitoring Board(Fees);

Susan Chon, MD, FAAD

No financial relationships exist with ineligible companies.

Sandhya Chowdary Deverapalli, MD, FAAD

No financial relationships exist with ineligible companies.

Ian Tattersall, MD, PhD, FAAD

EMD Serono – Consultant (1099 relationship)(Fees); MJH Life Sciences – Speaker(Fees); OnQuality Pharmaceuticals, Ltd. – Consultant (1099 relationship)(Fees);